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Autism is among the most clearly genetically determined of all
cognitive-developmental disorders, with males affected more of-
ten than females. We have analyzed autism risk in multiplex
families from the Autism Genetic Resource Exchange (AGRE) and
find strong evidence for dominant transmission to male offspring.
By incorporating generally accepted rates of autism and sibling
recurrence, we find good fit for a simple genetic model in which
most families fall into two types: a small minority for whom the risk
of autism in male offspring is near 50%, and the vast majority for
whom male offspring have a low risk. We propose an explanation
that links these two types of families: sporadic autism in the
low-risk families is mainly caused by spontaneous mutation with
high penetrance in males and relatively poor penetrance in fe-
males; and high-risk families are from those offspring, most often
females, who carry a new causative mutation but are unaffected
and in turn transmit the mutation in dominant fashion to their
offspring.
human genetics  neurodevelopmental disorders  population genetics
Autism Spectrum Disorder (ASD) (Online Mendelian Inher-itance in Man accession no. 209850) is characterized by
language impairments, social deficits, and repetitive behaviors;
can occur either sporadically (simplex) or in a familial (multi-
plex) pattern; occurs far more commonly in males; and has an
overall incidence of 1 in 150 births (1). Monozygotic (MZ)
twins show 70% concordance (2), higher with broader diag-
nostic criteria, and much higher than observed in dizygotic (DZ)
twins, strongly suggesting that autism is genetically determined.
Children with affected siblings have a higher risk than the
general population, suggesting that autism can be inherited at
least partially from preexisting genetic variants in parents.
Autism is likely to involve many genes. Linkage studies find no
single locus of major effect but rather a very minor increase in
allele sharing over the entire genome among concordant sibs
(3–9). Cytogenetic studies (10), and more recently copy number
analyses (9, 11, 12), support the idea that many loci may
contribute to the disease.
Sibling and DZ concordance rates are perhaps one-tenth of
MZ concordance rates, and this discrepancy, plus the suggestion
of a large number of risk loci, has led many to expect that autism
is attributable to complex multigenic interactions rather than
simple dominant or recessive mutations. However, our current
knowledge of genetic factors in autism suggests otherwise. Most
of what we know about heritable risk factors comes from
monogenic disorders, including fragile X syndrome (13–15),
Rett syndrome (16), and tuberous sclerosis (17). Furthermore,
cytogenetic findings and, more recently, copy number analysis
point to a higher incidence of spontaneous mutation in children
with sporadic autism (11), presumably occurring in a parental
germ line.
An alternate to the multigenic interaction hypothesis is worth
considering; most cases of autism are due to de novo mutation
in the parental germ line, which can strike any of a number of
critical loci. The large discrepancy in concordance rates between
MZ twins and siblings can be explained thus: inherited or de novo
mutation in the parental germ line affects MZ twins alike,
whereas sibling and DZ concordance rates represent a mixture
of modalities, sometimes inherited and sometimes de novo
mutation.
This hypothesis makes a strong prediction: de novo mutations
that can cause autism will also be found in resistant individuals,
especially females, and these relatively asymptomatic individuals
will mature to form high-risk families transmitting the mutation
and hence the disorder in nearly dominant fashion to male
offspring. To test one of our predictions, we analyzed autism risk
in the multiplex families collected by the Autism Genetic Re-
source Exchange (AGRE) consortium (18) and find strong
statistical evidence for families with a dominant pattern of
transmission to their male offspring.
To determine the abundance of such families in the popula-
tion, we extended our model beyond familial autism by incor-
porating two widely accepted ranges of parameters: the inci-
dence of autism in the general population and the recurrence
rate in siblings. Very simple models have a good fit to three
independent databases of autism incidence; the vast majority of
families have a low risk and contribute to the majority of autism,
and a tiny minority of high-risk families, for whom transmission
to male offspring is near 50%, contribute to the majority of the
remainder. The high-risk families can be explained readily as
generated by the expected number of offspring from low-risk
families who have sustained de novomutation but are themselves
relatively asymptomatic.
We therefore propose the following unified model for spo-
radic and inherited autism. The majority of autisms are a result
of de novo mutations, occurring first in the parental germ line.
For reasons yet to be determined, female offspring are consid-
erably more resistant to displaying the effects of such mutations
than are males. Resistant individuals, but females in particular,
carrying a mutation may marry and, with a probability of 50%,
pass the mutation to their offspring, who will display the
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symptoms with high probability if male. The latter process
accounts for a minority of autisms, but together these two
mechanisms are likely to account for the great majority of cases.
A consequence of this model is the explanation of increased
autism incidence as a function of parental age (19); germ-line
mutations can be expected to increase with age. The model also
leads to other testable deductions and suggests practical ap-
proaches in the design of future genetic studies of autism and
other disorders with similar epidemiological patterns, which will
be discussed in the paper.
Results
The Autism Family Databases. We first and most thoroughly ana-
lyzed the AGRE database, comprising extensive and validated
records of families with at least two affected children. Diagnoses
are based on the Autism Diagnostic Interview-Revised. In most
cases, the Autism Diagnostic Observation Schedule was also
administered. These tools were designed to detect deficits in
three behavioral domains: (i) reciprocal social interaction skills;
(ii) qualitative communication skills; and (iii) restricted, repet-
itive, and stereotyped patterns of behavior (20, 21). For milder
autism cases, the AGRE sample used a ‘‘broad-spectrum’’
category based on the presence of severe deficits in one of three
domains of functioning moderate deficits in two of three or
milder deficits in all three domains. We use the term ‘‘autism’’
or ‘‘Autism Spectrum Disorder’’ to refer to all three of these
patterns.
We used two other independent databases. The first and much
smaller from the University of Michigan was collected in part on
the referral of families with at least two autistic children. The
second, the Interactive Autism Network (IAN) Research Data-
base, is a large and rapidly growing database collected by
Internet registry, self referral, and self description (administered
by P.L. and K.L.). The summaries of data and further informa-
tion are in supporting information (SI) Tables 4 and 5 and
legends.
For purposes of modeling, in all databases, we counted MZ
siblings as one child, assigning the diagnosis of ‘‘affected’’ if even
one of the MZ sibs was so diagnosed. In AGRE there was
concordance of diagnosis in all 52 MZmale sibs and discordance
in 3 cases of 11 female MZ sibs. In IAN, there was 80%
concordance overall.
Transmission to Males in High-Risk Families. We look initially at
families where the first two children are affected, taking these to
be a subset of ‘‘high-risk’’ families, and consider when a third
child is born. There are 165 such families in AGRE, and the
third-born children can be divided by gender and affected status:
44 unaffected males, 42 affected males, 62 unaffected females,
and 17 affected females. It is apparent that the risk to the
third-born male child, i.e., his probability of being affected
conditional upon the first two children being affected, is nearly
50%, consistent with dominant transmission with high pen-
etrance. There is a lower risk for females (20%), consistent
with the overall lower incidence in females and explainable as
reduced penetrance in that gender.
Note that, by examining only the third-born children of
families already having two children with autism, we avoid the
potential bias of our risk estimate caused by stoppage. Stoppage
refers to the tendency of families to cease having offspring when
one of their children has autism. Stoppage can distort basic
assumptions of the likelihood method used in the next section
but is not operant in this data slice.
Risk estimates are affected by ascertainment bias. If the rate
of recruitment for families with three children with autism was
higher than the rate of recruitment for families with two, we
would see an inflated risk rate. Although there is no effort from
AGRE to favor families with more affected children once they
meet the basic requirement of having at least two, one could
argue that families with more affected children are more likely
to self report to the study. However, in that case, we would also
expect to see a distortion in the gender ratio of the third born,
because autism is more common in males. In fact, the proportion
of third-born children that are males is 86:165, or 52.1%, very
close to the ratio of males to females in that age group nationally
(105/205  51.2%) (22).
Based on the above insight, we can estimate the ascertainment
bias from the gender and affected status of the third child in the
165 families whose first two children are affected, and simulta-
neously estimate the risks for each gender, by expressing these
parameters in a likelihood equation and searching for the
maximum likelihood estimate (MLE) of these parameters. Let pf
and pm represent the risk of females and males respectively, and
r represent the ascertainment bias. Using a multinomial distri-
bution, we can express the likelihood relating gender bias and
ascertainment by the following equation:
Lr, pm, p f   nnAF nUF nAM nUM  rp fq fC 
nAF
 1  p fq fC 
nUF  rpmqmC 
nAM  1  pmqmC 
nUM
,
[1]
where nAF and nUF represent the number of affected and
unaffected females, nAM and nUM represent the males, and n 
nAF  nUF  nAM  nUM, qm and qf are the proportion of male
and female in the population, respectively, which equal 105/205
and 100/205 for this age group in the United States. In Eq. 1,C
rqf pf  qf(1  pf)  rqm pm  qm(1  pm) is a normalization
factor.
There is a wide range of possible values for the bias r that we
cannot rule out because of the small sample size; nevertheless the
data do not suggest strong ascertainment bias. For details, see SI
Fig. 1. The MLE for r is 1.14, a value we use for additional
analysis (see below). With the consideration of ascertaining bias,
theMLE for risk of males with autism is 0.46, still consistent with
a pattern of dominant transmission with high penetrance.
Estimating Simple Autism Risk Models. To determine whether the
observations consistent with dominant transmission in males
would hold under analysis of more of the AGRE data, we sought
a mathematical model fitting the data. At the same time, we
could estimate the proportion of such high-risk families in the
general population under the model by using accepted ranges of
autism incidence, R, and sibling recurrence, S, for the general
population. In the following, we restrict our analysis to male
offspring only.
We assume that each male–female progenitor pair has a
characteristic and time invariant risk x of producing male off-
spring with autism. The distribution of risk x across all progenitor
pairs can be described by a density function f(x) on [0, 1]. We
choose to model f(x) as having discrete risk components, cor-
responding to the intuition that there are a fixed number of
genetic states for progenitor pairs. Using families of up to five
offspring, there is information about the first five moments of
f(x), which in principle means that we can explore discrete
density functions with as many as five independent parameters,
that is, three-component mass functions. As it turns out, a
two-component mixture model suffices to fit the available autism
data very well.
Consider a family of n children. The probability that this family
has m children with autism is given by:
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Pn, m 
0
1 nm 1 xnm xm fxdx, [2]
a mixture of binomial distributions of n trials. Note that Eq. 2
provides a system of equations for the moments of f(x). The kth
moment of f(x) is defined as
mk 
0
1
xk fxdx. [3]
Theories and methods for statistical inference of f(x) in binomial
mixtures are well developed (23, 24). However, our problem is
unique in that families with fewer than two children with autism
are not observed in AGRE. Therefore, existing methods do not
directly apply to our data. In particular, we cannot infer the first
two moments from the AGRE data. Therefore, in our
maximum-likelihood approach, we use constraints for the first
two moments, derived from R and S, and conditional probabil-
ities for the likelihood function.
Let F(n, m) denote the ‘‘shape’’ of a family with n children of
whom m have autism, and let f(x) be a density function
parameterized by . Suppose that only families of shape F(n, m)
with m  2 are observed, and here we consider only those
families with at least three offspring. Under the assumption that
the diagnoses of children within a family are independent, and
that the families are themselves independent, a log-likelihood
function of this data is given by
LL 
n3
N 
m2
n
obsn , m logPn , m m  2 , [4]
whereN is the size of the largest sibships, obs(n,m) is the observed
number of families of shape F(n, m), and P(n, mm  2) denotes
the conditional probability P(n,m)/k2 P(n, k), where P is de-
fined by Eq. 2 with f(x)  f(x).
The first and second moments of f are constrained by R and
S, the probability that a second child will be diagnosed with
autism given that the first was, by the following two equations.

0
1
xfxdxm1 R [5]
m2 Sm1 S R. [6]
Therefore, given the rate of autism R and sibling recurrence rate
S, we have two constraints on the first two moments of f(x).
We consider f(x) as a k-component discrete density function
fx 
i0
k1
aixi, [7]
where  is the Dirac density function and the ai sum to one. Here
xi is the probability of an offspring with autism, and ai is the
proportion of families with that probability. We consider two-
and three-component parameterizations where the parameters 
are determined by ai and xi. To find the MLE for three-
component models under the moment constraints, we applied a
systematic grid search over all possible combinations of xi with
0  xi 	 xj  1 for 0  i 	 j  2 using a grid with spacing 104.
For a given combination of the three xi, the corresponding ai are
then uniquely determined by using the constraint equations on
the first two moments and the constraint that the ai sum to one.
For two-component models, the three constraints allow explo-
ration of all 0  xi  1 over a grid with the same resolution.
For our standard constraint parameters, we chose an overall
autism rate RT of 1/150 and a sibling recurrence rate ST of 10%.
Assuming an incidence ratio, males to females, of 3:1, we
calculated new parameters for males: an autism rate RM of 1%,
and a sibling recurrence rate SM of 15% (males born into a family
with a single previous male child, that child having autism). In
keeping with the preceding analysis, we make the conservative
assumption that the ascertainment bias is 1.14, that is, a family
with three or more children with autism is 1.14 times more likely
to be recruited to the study than a family with only two affected
(see SI Text for the mathematical details of the adjustment).
Table 1 describes the data from which we drew the values for
obs(n, m), a total of 145 informative families, from families with
up to five male children (female offspring were not counted). By
considering families with up to five male children, we have
enough data to examine a three-component discrete model (i.e.,
three risk types of families), but we examine first the parameters
of simpler nested models. The MLE for parameters of one- and
two-component models for males are shown in Table 2, first and
second rows. xi refers to the risk of the ith family type, and ai
refers to their proportion in all families. The one-component
model 2(m, 0) is in actuality a two-component model with x0, the
‘‘rate’’ of the first component, set to 0. That is, there are families
Table 1. Family shapes: Male offspring
No. of
male
children
No. of males with autism
2 3 4 5
3 85 26
4 19 9 1
5 2 2 1 0
Data were extracted from the AGRE database, counting the number of
male offspring and of affected male offspring for each family.
Table 2. Maximum-likelihood estimates for several models
Model
type
Data
source a0 x0 a1 x1 a2 x2 LL
2(m,0) AGRE 0.9333 0 0.0667 0.15 112.70
2(m) AGRE 0.9923 0.0067 0.0077 0.434 88.211
3(m) AGRE 0.7961 0.0067 0.1963 0.0068 0.0076 0.437 88.210
2(m/f/p) AGRE 0.9941 0.0072 0.0059 0.501 783.02
2(m) IAN 0.9932 0.0069 0.0068 0.462 38.821
2(m/f/p) IAN 0.9913 0.0066 0.0087 0.416 326.49
Models 2(m) and 3(m) are the two- and three-component models for males only, respectively. Model 2(m,0) is
for the model where x0 is set to 0. Model 2(m/f/p) is for mixed gender (see SI Text and text below).
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with zero risk, and the rest have high-risk x1. In model 2(m), there
is no constraint for x0. That is, there are two types of families,
each with uniform risk (x0 and x1). We achieve a much higher
likelihood with the two-component model, with a P value equal
to 2.59e-12 by 2 approximation and 0 of 1,000 by Monte Carlo
simulation.
We have explored ranges of the autism rate for males, RM,
from 0.5% to 1.2% and ranges of the sibling recurrence rate for
males, SM, from 5% to 20% for model 2(m) (see SI Table 6), and
it is satisfying to note that, regardless of R and S, the MLE of
parameters impute low-risk families with transmission rates
ranging from 0.0027 to 0.0111 (first-component rate x0) and
high-risk families with transmission rates from 0.429 to 0.519
(second-component rate x1). Obviously, the second-rate com-
ponent is always close to 0.5, yet nothing about Mendelian
inheritance is embodied in our mathematical methods. Thus, we
interpret families with high risk as transmitting to males in a
dominant pattern with high penetrance, and this conclusion is
largely independent for a wide range of incidence and sibling
recurrence.
We next looked at MLE for parameters of the three-
component model 3(m), males only, shown in Table 2, row 3,
using the same constraint parameters, RM and SM. Despite
providing a model with two extra parameters, presenting an
opportunity to choose another component for risk, the MLE
parameters show one high-rate component (x2) that is nearly
50%, and two low-risk components that are essentially indistin-
guishable. Although there is no evidence for an intermediate-
risk component, we examine its possibility below. The maximum
likelihood of the three-component model is marginally higher
than for the two-component model and not of any statistical
significance (P value is 0.999 by 2 approximation and 0.86 by
Monte Carlo simulation). Again, varying the values for rates of
autism or sibling recurrence does not change this picture.
In summary, the MLE of the discrete-component models for
males only imply a pattern consistent with a clear genetic
interpretation; the population mixes two kinds of families:
high-risk families, where the probability of a male offspring with
autism is near 50%; and low-risk families. We interpret the
high-risk families as transmitting the disorder in a dominant
manner, with nearly complete penetrance for males.
Goodness of Fit of Simple-Risk Models to AGRE and Other Data Sets.
To assess how well the statistical models fit the observations, we
performed goodness-of-fit tests on the AGRE data for the
two-component model, male only, listed as 2(m) in Table 2. A
similar model that includes female offspring can be constructed
from a two-component discrete-density function by postulating
a uniform rate of penetrance in females [see 2(m/f/p) in Table 2
and SI Text). We used Pearson 2 as the test statistics, summa-
rizing the difference between observed number of F(n, m)
families and expected number of F(n, m) families from our
model, for n  3,4,5 and 2  m  n. The P values, obtained
empirically from 1,000 random simulations (details described in
SI Text), were equal to 0.98 and 0.41 for 2(m) and 2(m/f/p),
respectively, suggesting our risk models fit the data well.
We performed goodness-of-fit analysis on two other data sets.
For IAN, we used the estimated ascertainment bias of 1.06 (see
below); otherwise, we used the same parameters (i.e., the ai and
xi) estimated from AGRE data. For the University of Michigan
data set, we obtained P values equal to 0.24 and 0.12 for 2(m) and
2(m/f/p), respectively (21 informative families for males only and
40 informative families for mixed gender). An analysis of the
IAN database, an ongoing and expanding database, which, like
AGRE, is based on self referral, had P values equal to 0.54 and
0.04 for 2(m) and 2(m/f/p), respectively (60 informative families
for males only and 154 informative families for mixed gender).
The IAN database was large enough (3,000 families) for us to
perform an ascertainment bias based on gender asymmetry,
similar to what was described in Eq. 1, and also independent
maximum-likelihood estimation. The results yielded a bias of
1.26 for accruing families of size two with two affected children
over families of size two with only the first child affected. For
families of size three with three affected children over families
of size three with only the first two children affected, the bias was
only 1.06. These biases are consistent with our analysis of
ascertainment bias in AGRE. The model parameters we derived
from this database were very similar to those we derived from
AGRE, with high-risk transmission equal to 0.46 and 0.42 for the
2(m) and 2(m/f/p) models, respectively (row 5 and row 6, Table
2). The family risk patterns inferred from these data are thus
remarkably similar to that from AGRE.
The same simple models of risk fit the three databases well.
Size and Contribution of Risk Classes Using Simple and Complex
Density Functions. Our simple two-component model [2(m) in
Table 2] estimates that two-thirds and one-third of autism cases
are contributed from low- and high-risk families, respectively.
However, our biological conclusions do not depend on such a
unique model. Although the data are always insufficient to
determine the actual probability distribution of transmission in
families, we can explore the likely functions within the same
general classes of density functions and examine their properties,
such as the size and contribution to autism from the various risk
classes. To do this, we capped the risk at 0.5, the maximum
expected risk for a dominantly inherited. model. We used our
standard values for RM and SM and accepted for analysis those
three-component mass functions with log-likelihood given the
AGRE data within 1.92 ( 0.51,0.95
2 ) of the maximum log-
likelihood. We analyzed 10,000 three-component mass functions
randomly selected from all such functions found during a grid
search. We also broadened the class of allowed density functions
beyond just three discrete components by considering the class
of 150-component mass functions, thereby approximating the
properties of continuous density functions. We used a Markov
chain Monte Carlo (MCMC) method (25) to uniformly sample
10,000 150-component mass functions that satisfied the first and
second moment constraints and gave a good fit to the data (with
P 0.05 in the Pearson 2 goodness-of-fit test). MCMC samples
were collected every 1,000 iterations after an initial 5 million
iterations. Details of the sampling method will be presented
subsequently, along with some theoretical discussions relating to
moment analysis and population genetics.
For each density function, we determined the size and contri-
bution to autism from families with 0 to 0.01 risk (low risk), 0.1 to
0.3 risk (intermediate risk, which would include recessive patterns
of transmission), and 0.3 to 0.5 risk (high risk, which would include
dominant patterns of transmission with partial to complete pen-
etrance). The mean and standard deviation of these values from
each function class are summarized in Table 3. It is clear from our
analysis that the major contribution to autism comes from low-risk
families, those below themean expected risk. Also, the contribution
from high-risk families in general exceeds the overall contribution
from intermediate risk families, whether we inspect 150- or 3-com-
ponent mass functions.
By examining each particular reasonable density function
from either class, contribution from the high-risk range exceeds
the contribution from the intermediate risk range 92% of the
time. Contribution from high-risk families exceeds even more
broadly defined intermediate-risk families (range from 0.01 to
0.3) 65% of the time for either function class. We interpret this
as evidence that, in a purely genetic model, the families with a
dominant pattern contribute more cases than the families with
a more complex genetic transmission pattern.
We do not know with certainty that the MCMC process (used
for the 150-component mass functions) reached convergence,
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hence the sampling obtained may not be uniform from the
targeted function space. However, our above conclusions are
robust to the possibility of nonuniformity. This is because we
deliberately chose our starting point for the MCMC to be the
150-component mass function that has the least contribution
from the high-risk families. We obtained this function using
mathematical programming under two linear constraints for first
two moments and a quadratic constraint for the remaining
moments using the Pearson 2 statistic.
Discussion
We must emphasize at the outset that our biological interpre-
tation of the risk models assumes that risk is determined by
genetic factors, and thus, except for their appealing simplicity,
the risk models themselves should not be taken as evidence for
genetic causation. We cannot rule out environmental factors,
such as complications during pregnancy, contributing to the
observed risk data, and the presence of these factors could
impact our biological interpretation and some of our modeling
assumptions. Nevertheless, in what follows, we assume a genetic
basis for risk, justified largely by MZ and DZ twin studies.
Analysis of three databases shows that a simple-risk model has
good fit for the incidence of autism in males, in which families
fall into two major types: families for whom the risk of autism in
male offspring is nearly 50%, as expected for dominant trans-
mission with high penetrance; and families for whom male
offspring have a low risk. The two-component model fits female
incidence well if we simply add a penetrance factor of 0.3 for
females. The two-component model is vastly superior to the
single-component model. This latter finding is in keeping with
the observation that there are at least two distinct genetic
mechanisms for acquiring autism, one through de novomutation
in simplex families, and one through inheritance in multiplex
families (11). Indeed, deleterious de novomutations, which enter
the gene pool for only a brief time, may be the simplest way in
which to explain the discrepancy between MZ and DZ concor-
dance rates and the origin of low- and high-risk families.
The data in our study do not rule out recessive modes of
inheritance or a variety of more-complex genetic states that
could give rise to families with gradations of risk. Nevertheless,
if we exclude the possibility of families with greater than a
dominant risk pattern, examination of simple and complex
discrete density functions with plausible likelihood or 2 mea-
sures suggests that intermediate risk families with a recessive
pattern of transmission would contribute less to autism incidence
than families with a dominant pattern, and overall contribution
is greatest from low-risk families.
We need to consider what factors might lead to spurious
conclusions. The most obvious are overdiagnosis, stoppage, and
ascertainment bias. Overdiagnosis seems to us unlikely. Stan-
dardized interviews were performed on each AGRE patient, so
assessment is as objective as possible at the present time.
Stoppage, the tendency to curtail procreation given affected
offspring, could undermine the assumptions of the likelihood
model. But stoppage is not relevant in the analysis of the
third-born children, which showed evidence of families with the
dominant pattern. A criticism of ascertainment bias is harder to
rebut, because families with more than two affecteds might have
a higher likelihood of being collected than families with just two.
However, this potential bias is mitigated by two conditions:
recruitment was initiated by self referral of the family, not by the
encounter with a proband; and the collection was amassed over
a 10-year interval. In addition, we have developed a method
based on the asymmetry of gender ratios to estimate ascertain-
ment bias and find only a minor effect in both AGRE and IAN
databases.
In the following several paragraphs, we will consider the
biological implications if the high-risk families are transmitting
an allele in a dominant fashion and with high penetrance in
males. Such families raise the question: what sort of mutation
can cause autism, can be present in an apparently unaffected
parent, and then can be transmitted to an offspring in a
dominant manner? This pattern could be explained by X-
linked mutations, but we see insufficient evidence of increased
sharing of maternal X in concordant siblings in the AGRE
data set (7). The most likely remaining explanation is disrup-
tions on a single parental chromosome, with incomplete
penetrance creating carrier states. Females are especially
resistant and make logical carriers, but discordance between
MZ twins suggests an ‘‘Autism Spectrum Disorder genotype’’
can exist in the absence of phenotype in either gender. To
explain greater penetrance in males, we need merely consider
the hypothesis that autism involves loss of cognitive abilities
related to social skills, language, and repetitive behavior that
may already be targets of sexual dimorphism (26–28) and
hence these traits are already sensitive to perturbation.
Where are these high risk families coming from? We propose
that a significant proportion of sporadic autism is caused by de
novo mutation, deletions, duplications, other genomic rear-
rangements, or point mutations in the germ line of one parent
that can cause loss-of-function (haploinsufficiency) or gain of
function to any of a large number of target genes. This can occur
in any family, regardless of genetic background, and can appear
in any offspring, regardless of gender. Offspring with mild
disorders or asymptomatic carriers such as females, may marry
and have children who will inherit the mutation in a dominant
fashion. With our standard parameters (RT  1/150, ST  10%,
3:1 males to females), the number of asymptomatic females
would, by symmetry arguments, be 2 in 300 (0.0067) female
newborns. This is the right magnitude needed to explain the
proportion of high-risk families, which we estimate as 0.0077 (see
Table 2, row 2, value a1).
We observe de novomutation in 10% of children with sporadic
autism, significantly more often than observed in either healthy
children or children frommultiplex families (11).We believe that
10% is a gross underestimate because of the low resolution of the
technique for discovering these copy-number mutations. The
true rate of de novo copy number mutations in children with
autism could well be three times that number, and we do not yet
know the frequency of spontaneous point mutation. Thus the
rate of spontaneous mutation of all types reasonably can be
expected to account for the majority of sporadic autism. The
great majority of de novo mutations we observe in sporadic
autism are deletions (11), although other types of mutation, such
Table 3. Mean (standard deviation) of sizes and contributions to autism of various risk classes
Model type aL aI aH aLxL/R aIxI/R aHxH/R aHxHaIxI aHxHaBIxBI
3-component 0.9325 (0.0975) 0.0032 (0.0063) 0.0071 (0.0019) 0.474 (0.183) 0.051 (0.092) 0.303 (0.051) 0.921 0.653
150-component 0.9735 (0.004) 0.0089 (0.002) 0.0064 (0.0006) 0.513 (0.02) 0.172 (0.03) 0.260 (0.02) 0.949 0.731
Columns aL, aI, and aH are the mean (standard deviation) of sizes of low-, intermediate-, and high-risk classes, respectively. Columns aLxL/R, aIxI/R, and aHxH/R
are the mean (standard deviation) of contributions for each class. Columns aHxH/R, aHxHaIxI, and aHxHaBIxBI show the proportionate number of times that
contribution from the high-risk range exceeds the contribution from the intermediate-risk and the broadly defined intermediate-risk ranges, respectively.
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as duplication, do occur (29). Deletions will most likely create
haploinsufficiency. There is no lack of examples of haploinsuf-
ficiency affecting neurological development, behavior, and cog-
nition (30). The association of chromosomal abnormalities and
submicroscopic deletions with autism supports the idea that gene
imbalance can contribute to the disorder.
Our conjecture makes strong predictions, some testable in the
short term. One parent in a high-risk family may have a de novo
mutation. We predict this will be more commonly observed in
the mother, and high risk should follow one parent when they
have offspring with another partner.
We have achieved a simple model for autism in large part by
focusing on the pattern of inheritance in males and using broad
diagnostic criteria, while ignoring the details of the phenotype.
Thus, our study does not directly address very important ques-
tions: what ‘‘modifier’’ genes influence the phenotypic manifes-
tations of the disorder, the variable severity of autism in siblings,
and the penetrance of autism in females. In particular, the high
concordance in MZ females and the low penetrance in females
suggest that additional genetic factors moderate incidence in that
gender. Guided by our model, we propose that, whereas genetic
association studies will fail to find causative mutations, such
studies can find modifier genes.
Spontaneous mutation should be considered as a cause for any
disorder clearly genetic in origin that reduces fecundity yet
recurs in the population and particularly if the incidence is
related to the age of the parents at conception. Besides autism,
this potentially includes other severe developmental, metabolic,
or neuropsychiatric disorders such as congenital heart disease,
cerebellar dysfunction, morbid obesity, and severe mood and
cognitive disabilities. The overall rate of de novo mutation in
humans per generation is not a well determined figure and could
be surprisingly high in light of our previous work (11). Finding
de novo mutations by examining parent–child trios should
become increasingly powerful over the next few years.
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